Patients given semaglutide – the key ingredient in Ozempic and Wegovy – were less likely to progress to kidney failure or need transplants in what has been hailed a ‘game-changer’.Patients given semaglutide – the key ingredient in Ozempic and Wegovy – were less likely to progress to kidney failure or need transplants in what has been hailed a ‘game-changer’.Read MoreHealth News | Mail Online
![](https://ourbodyhealth.info/wp-content/uploads/2024/05/85287367-0-image-a-20_1716541511558-rjLGsz.jpeg)